Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.14 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) EV to CFO (2017 - 2021)

Updated

Sangamo Therapeutics' EV to CFO came in at 10.11 for Q1 2021, up 9.0% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) EV to CFO (2017 - 2021) Analysis & Trends

Over the trailing twelve months to Mar 31, 2021, Sangamo Therapeutics reported EV to CFO of -6.16; for FY2020, it was 9.27.

  • Going back by year, EV to CFO was 21.17 in FY2018 (-79.6%) and 103.81 in FY2017.
  • The Q1 2021 figure represents the highest quarterly EV to CFO since Q1 2019.
  • Business Quant data shows SGMOQ's EV to CFO at 9.27 (Q4 2020), 4.48 (Q3 2020) and 7.35 (Q2 2020) in the three quarters before Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Sangamo Therapeutics 39.23 Mn -74.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 10.11
Dec 31, 2020 9.27
Sep 30, 2020 4.48
Jun 30, 2020 7.35
Mar 31, 2019 78.44
Dec 31, 2018 21.17
Sep 30, 2018 21.17
Jun 30, 2018 12.59
Mar 31, 2018 232.61
Dec 31, 2017 103.81
Sep 30, 2017 63.06
Jun 30, 2017 33.75
API Access

Sangamo Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY